The goal of this parallel-group, two-arm, assessor-blinded, randomised clinical trial is to investigate the effects of reducing physical activity on food intake and satiety in physically active and healthy males, 40-55 years of age. The main questions it aims to answer are: * Does physical inactivity affect GLP-1 stimulated food intake? * Does physical inactivity affect food preferences, satiety and other mechanisms supporting appetite regulation? Participants will be randomised (1:1) to two weeks of either no intervention (control group) or inactivity. Inactivity will be implemented as cessation of active commuting and all other structured exercise. Furthermore, steps will be reduced to a maximum of 1500 steps/day. Researchers will compare the inactivity group to the control group to see if physical inactivity impairs appetite regulation.
To contextualize the changes in ad libitum food intake driven by two weeks of physical inactivity, a sub-study will assess the effect of GLP-1 infusion on ad libitum food intake compared with a saline control in 20 participants included based on same eligibility criteria as in the main study. The estimated GLP-1 induced change in ad libitum food intake will be descriptively compared to the estimated GLP-1 + inactivity induced change in ad libitum food intake (main-study) to provide context for any attenuation in appetite suppression observed in the main-study. Outcomes related to subjective appetite measures (hunger, satiety, and food preference) will also be assessed in this way. The primary hypothesis is that GLP-1 infusion will suppress appetite and reduce ad libitum food intake compared with saline control. The secondary hypothesis is that GLP-1 infusion will diminish subjective feelings of hunger and increase satiety.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
40
Inactivity will be implemented as cessation of active commuting and all other structured exercise. Furthermore, steps will be reduced to a maximum of 1500 steps/day.
Copenhagen University Hospital
Copenhagen, Denmark
RECRUITINGThe change in food intake at an ad libitum meal during GLP-1 infusion
Food intake will be evaluated as ingested food in grams
Time frame: From baseline (week 0) to follow-up (week 2).
The change in preference for unhealthy food ( combined score for high fat food, savory food, and sweet food).
Evaluated by visual food stimuli combined with eye tracking
Time frame: From baseline (week 0) to follow-up (week 2)
The change in subjective experience of severity and type of food cravings
Evaluated by the Control of Eating Questionnaire.
Time frame: From baseline (week 0) to follow-up (week 2)
The change in subjective feeling of satiety
Evaluated by a visual analogue scale
Time frame: From baseline (week 0) to follow-up (week 2)
The change in subjective felling of hunger
Evaluated by a visual analogue scale
Time frame: From baseline (week 0) to follow-up (week 2)
The change in satiety composite appetite score
Calculated from visual analog scales
Time frame: From baseline (week 0) to follow-up (week 2)
Sub study
Comparison between Ad libitum meal +/- GLP-1 infusion on primary and secondary outcomes of the primary study.
Time frame: Sub study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.